title: Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al.
authors.forename: R
authors.initials: R
authors.lastname: Jean
authors.forename: E
authors.initials: E
authors.lastname: Bastard
authors.forename: E
authors.initials: E
authors.lastname: Cretel
authors.forename: P
authors.initials: P
authors.lastname: Lefèvre
authors.forename: J M
authors.initials: JM
authors.lastname: Durand
mesh_terms: D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D012449:Safety
chemical_list: D016756:Immunoglobulins, Intravenous